Cronos Group Pays $110.4 Million for Option to Acquire 10.5% of Private MSO PharmaCann
Cronos Group Announces Strategic Investment in PharmaCann, a Leading U.S. Cannabis Company Investment is Expected to Position Cronos Group to Benefit from Rapid Growth in the U.S. Cannabis Market PharmaCann...